RE:Whats nextGreat summary Tricky, another great update would be on KSA....do we have more info on hows its going on the Dammam grading center to get the other 22 countries in the surrounding areas to begin trials at least....
cheers
The results were convincing and generated a very positive endorsement from the medical team involved. Kanhoor has agreed to extend its agreement with DIAGNOS for three years. “Our objective is to screen every diabetic patient in the Kingdom with CARA in extending the services to the private health sector, NGO’s and in the public system as well. “Our short term objective is to screen 35,000 in the coming year. We’re in discussions with other health providers with our neighbouring countries in the Middle East so they can also benefit from early detection,” said Rashid Al Mugait, president of Kanhoor.
In order to support this new service, we are announcing the creation of grading centre in Dammam. The grading centre will use DIAGNOS AI (Artificial Intelligence) technology to support its activity and it will be connect virtually to all the screening clinics of Kanhoor Medical Go. “Right at the screening site, at risk patients will know right away if additional treatments are needed to protect their vision. The solution will help us to screen more patients and at lower cost. The patients will gain a better access to care to avoid risks, delay and undue stress for them and their families,“ said Dr Abdulaziz Rushood from Al Kahhal Medical Complex. Dr Rushood is an ophthalmologist, vitreo retinal surgeon and Assistant Professor at King Fahd University Hospital.
“This announcement by Kanhoor is very strategic for the growth of DIAGNOS in Saudi Arabia, the Gulf region and the Middle-East. We now have a highly technical savvy partner with strong ties in the market to sell our technology in this region of 22 countries. By creating a grading center in Saudi Arabia, we will strengthen our collaboration with this medical community and tremendously increase the efficiency of the screening process to benefit the patients,”
Read more at https://www.stockhouse.com/news/press-releases/2018/02/27/after-successful-screening-of-2-500-patients-as-part-of-a-pilot-project-with#RkvRdwfwXRMKwOQp.99